CHEMED CORP (CHE) Fundamental Analysis & Valuation
NYSE:CHE • US16359R1032
Current stock price
387.62 USD
+1.78 (+0.46%)
At close:
387.62 USD
0 (0%)
After Hours:
This CHE fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. CHE Profitability Analysis
1.1 Basic Checks
- In the past year CHE was profitable.
- In the past year CHE had a positive cash flow from operations.
- CHE had positive earnings in each of the past 5 years.
- Each year in the past 5 years CHE had a positive operating cash flow.
1.2 Ratios
- CHE's Return On Assets of 17.24% is amongst the best of the industry. CHE outperforms 100.00% of its industry peers.
- Looking at the Return On Equity, with a value of 27.08%, CHE belongs to the top of the industry, outperforming 94.00% of the companies in the same industry.
- CHE's Return On Invested Capital of 21.08% is amongst the best of the industry. CHE outperforms 95.00% of its industry peers.
- CHE had an Average Return On Invested Capital over the past 3 years of 21.04%. This is significantly above the industry average of 8.51%.
- The 3 year average ROIC (21.04%) for CHE is below the current ROIC(21.08%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROIC | 21.08% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
1.3 Margins
- With an excellent Profit Margin value of 10.48%, CHE belongs to the best of the industry, outperforming 97.00% of the companies in the same industry.
- CHE's Profit Margin has declined in the last couple of years.
- The Operating Margin of CHE (14.01%) is better than 87.00% of its industry peers.
- CHE's Operating Margin has declined in the last couple of years.
- CHE has a Gross Margin of 32.54%. This is in the better half of the industry: CHE outperforms 66.00% of its industry peers.
- CHE's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% |
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
2. CHE Health Analysis
2.1 Basic Checks
- The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CHE is creating value.
- CHE has less shares outstanding than it did 1 year ago.
- CHE has less shares outstanding than it did 5 years ago.
- The debt/assets ratio for CHE is higher compared to a year ago.
2.2 Solvency
- An Altman-Z score of 10.81 indicates that CHE is not in any danger for bankruptcy at the moment.
- The Altman-Z score of CHE (10.81) is better than 96.00% of its industry peers.
- The Debt to FCF ratio of CHE is 0.03, which is an excellent value as it means it would take CHE, only 0.03 years of fcf income to pay off all of its debts.
- CHE has a better Debt to FCF ratio (0.03) than 92.00% of its industry peers.
- CHE has a Debt/Equity ratio of 0.01. This is a healthy value indicating a solid balance between debt and equity.
- CHE has a Debt to Equity ratio of 0.01. This is amongst the best in the industry. CHE outperforms 83.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Altman-Z | 10.81 |
ROIC/WACC2.35
WACC8.96%
2.3 Liquidity
- A Current Ratio of 1.05 indicates that CHE should not have too much problems paying its short term obligations.
- CHE has a Current ratio of 1.05. This is in the lower half of the industry: CHE underperforms 66.00% of its industry peers.
- A Quick Ratio of 1.03 indicates that CHE should not have too much problems paying its short term obligations.
- CHE has a worse Quick ratio (1.03) than 64.00% of its industry peers.
- CHE does not score too well on the current and quick ratio evaluation. However, as it has excellent solvency and profitability, these ratios do not necessarly indicate liquidity issues and need to be evaluated against the specifics of the business.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 |
3. CHE Growth Analysis
3.1 Past
- The earnings per share for CHE have decreased by -6.70% in the last year.
- Measured over the past 5 years, CHE shows a small growth in Earnings Per Share. The EPS has been growing by 3.61% on average per year.
- CHE shows a small growth in Revenue. In the last year, the Revenue has grown by 4.06%.
- The Revenue has been growing slightly by 4.00% on average over the past years.
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
3.2 Future
- Based on estimates for the next years, CHE will show a quite strong growth in Earnings Per Share. The EPS will grow by 10.57% on average per year.
- CHE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 5.67% yearly.
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.
4. CHE Valuation Analysis
4.1 Price/Earnings Ratio
- CHE is valuated rather expensively with a Price/Earnings ratio of 17.95.
- 74.00% of the companies in the same industry are more expensive than CHE, based on the Price/Earnings ratio.
- CHE's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 27.18.
- CHE is valuated correctly with a Price/Forward Earnings ratio of 16.07.
- CHE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CHE is cheaper than 72.00% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of CHE to the average of the S&P500 Index (37.96), we can say CHE is valued rather cheaply.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.95 | ||
| Fwd PE | 16.07 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, CHE is valued a bit cheaper than the industry average as 63.00% of the companies are valued more expensively.
- 71.00% of the companies in the same industry are more expensive than CHE, based on the Price/Free Cash Flow ratio.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 16.4 | ||
| EV/EBITDA | 12.49 |
4.3 Compensation for Growth
- CHE's PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates a correct valuation of the company.
- The excellent profitability rating of CHE may justify a higher PE ratio.
PEG (NY)1.54
PEG (5Y)4.97
EPS Next 2Y11.6%
EPS Next 3Y10.57%
5. CHE Dividend Analysis
5.1 Amount
- With a yearly dividend of 0.61%, CHE is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.47, CHE pays a better dividend. On top of this CHE pays more dividend than 81.00% of the companies listed in the same industry.
- With a Dividend Yield of 0.61, CHE pays less dividend than the S&P500 average, which is at 1.82.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- On average, the dividend of CHE grows each year by 11.06%, which is quite nice.
- CHE has been paying a dividend for at least 10 years, so it has a reliable track record.
- CHE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)11.06%
Div Incr Years17
Div Non Decr Years22
5.3 Sustainability
- 11.95% of the earnings are spent on dividend by CHE. This is a low number and sustainable payout ratio.
- CHE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP11.95%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
CHE Fundamentals: All Metrics, Ratios and Statistics
387.62
+1.78 (+0.46%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-25 2026-02-25/amc
Earnings (Next)04-23 2026-04-23
Inst Owners104.27%
Inst Owner Change0.04%
Ins Owners1.51%
Ins Owner Change-1.34%
Market Cap5.34B
Revenue(TTM)2.53B
Net Income(TTM)265.24M
Analysts75
Price Target451.86 (16.57%)
Short Float %3.2%
Short Ratio1.76
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend2.24
Dividend Growth(5Y)11.06%
DP11.95%
Div Incr Years17
Div Non Decr Years22
Ex-Date02-23 2026-02-23 (0.6)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-6.47%
Min EPS beat(2)-10.06%
Max EPS beat(2)-2.88%
EPS beat(4)1
Avg EPS beat(4)-6.89%
Min EPS beat(4)-15.11%
Max EPS beat(4)0.5%
EPS beat(8)1
Avg EPS beat(8)-5.02%
EPS beat(12)3
Avg EPS beat(12)-3.1%
EPS beat(16)7
Avg EPS beat(16)-1.84%
Revenue beat(2)0
Avg Revenue beat(2)-2.56%
Min Revenue beat(2)-3.96%
Max Revenue beat(2)-1.17%
Revenue beat(4)0
Avg Revenue beat(4)-1.96%
Min Revenue beat(4)-3.96%
Max Revenue beat(4)-0.19%
Revenue beat(8)0
Avg Revenue beat(8)-1.64%
Revenue beat(12)2
Avg Revenue beat(12)-1.3%
Revenue beat(16)2
Avg Revenue beat(16)-1.4%
PT rev (1m)-20.25%
PT rev (3m)-22.86%
EPS NQ rev (1m)-3.33%
EPS NQ rev (3m)-11.53%
EPS NY rev (1m)-0.56%
EPS NY rev (3m)-6.29%
Revenue NQ rev (1m)-0.03%
Revenue NQ rev (3m)-2.46%
Revenue NY rev (1m)-0.04%
Revenue NY rev (3m)-1.43%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 17.95 | ||
| Fwd PE | 16.07 | ||
| P/S | 2.11 | ||
| P/FCF | 16.4 | ||
| P/OCF | 13.75 | ||
| P/B | 5.45 | ||
| P/tB | 23.24 | ||
| EV/EBITDA | 12.49 |
EPS(TTM)21.59
EY5.57%
EPS(NY)24.11
Fwd EY6.22%
FCF(TTM)23.64
FCFY6.1%
OCF(TTM)28.2
OCFY7.27%
SpS183.73
BVpS71.13
TBVpS16.68
PEG (NY)1.54
PEG (5Y)4.97
Graham Number185.88
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 17.24% | ||
| ROE | 27.08% | ||
| ROCE | 28.33% | ||
| ROIC | 21.08% | ||
| ROICexc | 22.41% | ||
| ROICexgc | 60.78% | ||
| OM | 14.01% | ||
| PM (TTM) | 10.48% | ||
| GM | 32.54% | ||
| FCFM | 12.86% |
ROA(3y)17.23%
ROA(5y)17.8%
ROE(3y)26.22%
ROE(5y)30.6%
ROIC(3y)21.04%
ROIC(5y)22.31%
ROICexc(3y)24.14%
ROICexc(5y)24.65%
ROICexgc(3y)64.18%
ROICexgc(5y)68.12%
ROCE(3y)28.21%
ROCE(5y)29.9%
ROICexgc growth 3Y-2.67%
ROICexgc growth 5Y-7.4%
ROICexc growth 3Y-2.26%
ROICexc growth 5Y-2.45%
OM growth 3Y-4.39%
OM growth 5Y-2.39%
PM growth 3Y-3.57%
PM growth 5Y-7.36%
GM growth 3Y-3.17%
GM growth 5Y-0.72%
F-Score6
Asset Turnover1.64
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.01 | ||
| Debt/FCF | 0.03 | ||
| Debt/EBITDA | 0.03 | ||
| Cap/Depr | 96.84% | ||
| Cap/Sales | 2.48% | ||
| Interest Coverage | 263.51 | ||
| Cash Conversion | 92.61% | ||
| Profit Quality | 122.71% | ||
| Current Ratio | 1.05 | ||
| Quick Ratio | 1.03 | ||
| Altman-Z | 10.81 |
F-Score6
WACC8.96%
ROIC/WACC2.35
Cap/Depr(3y)89.6%
Cap/Depr(5y)92.99%
Cap/Sales(3y)2.34%
Cap/Sales(5y)2.49%
Profit Quality(3y)114.97%
Profit Quality(5y)107.83%
High Growth Momentum
Growth
EPS 1Y (TTM)-6.7%
EPS 3Y3%
EPS 5Y3.61%
EPS Q2Q%-6%
EPS Next Y11.69%
EPS Next 2Y11.6%
EPS Next 3Y10.57%
EPS Next 5YN/A
Revenue 1Y (TTM)4.06%
Revenue growth 3Y5.82%
Revenue growth 5Y4%
Sales Q2Q%-0.1%
Revenue Next Year4.7%
Revenue Next 2Y5.46%
Revenue Next 3Y5.67%
Revenue Next 5YN/A
EBIT growth 1Y-12.87%
EBIT growth 3Y1.18%
EBIT growth 5Y1.52%
EBIT Next Year25.06%
EBIT Next 3Y13.68%
EBIT Next 5YN/A
FCF growth 1Y-11.55%
FCF growth 3Y8.82%
FCF growth 5Y-5.44%
OCF growth 1Y-7%
OCF growth 3Y7.8%
OCF growth 5Y-4.52%
CHEMED CORP / CHE Fundamental Analysis FAQ
What is the fundamental rating for CHE stock?
ChartMill assigns a fundamental rating of 7 / 10 to CHE.
What is the valuation status of CHEMED CORP (CHE) stock?
ChartMill assigns a valuation rating of 5 / 10 to CHEMED CORP (CHE). This can be considered as Fairly Valued.
What is the profitability of CHE stock?
CHEMED CORP (CHE) has a profitability rating of 8 / 10.
Can you provide the PE and PB ratios for CHE stock?
The Price/Earnings (PE) ratio for CHEMED CORP (CHE) is 17.95 and the Price/Book (PB) ratio is 5.45.
What is the financial health of CHEMED CORP (CHE) stock?
The financial health rating of CHEMED CORP (CHE) is 8 / 10.